drugset / Trial / NCT01322321
ACZ885 in Type 1 Diabetes Mellitus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will assess the safety and efficacy of ACZ885 on stimulated C-peptide during a mixed meal test in patients with newly-diagnosed type 1 diabetes mellitus.
Timeline
- Start
- 2011-03
- Primary completion
- 2011-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Canakinumab | Monoclonal antibody | — | — |